What Researchers Did
Researchers conducted a trial to evaluate hyperbaric oxygen therapy in 10 patients with perianal Crohn's disease that had not responded to conventional treatments.
What They Found
Complete healing was observed in 5 out of 10 patients after one to two courses of hyperbaric oxygen therapy, with an additional 2 patients achieving complete healing after three courses. Overall, 70% of patients experienced complete healing, and 1 patient improved while 2 did not improve, with no adverse effects reported and no recurrence over an 18-month follow-up.
What This Means for Canadian Patients
For Canadian patients suffering from perianal Crohn's disease that has not responded to standard therapies, hyperbaric oxygen therapy may offer a new treatment option. This could potentially lead to significant symptom relief and healing for those with severe, persistent perianal involvement.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
A significant limitation of this study is its small sample size of only 10 patients, which means the findings are preliminary and require further validation in larger trials.